Skip to main content

Office Medical

Multi-Tenant Fresenius MOB

1340 Belmont Ave, Youngstown, OH 44504

Listing Price: $4,150,000

Cap Rate
8.00%
Gross SF
23,611
Rentable SF
23,611
Price/Gross SF
$175.77
Occupancy
100.0%
Year Built
1954
Lot Size
1.50 acres

Investment Overview

- Fully Occupied Medical Office with Proximity to Hospital Campus

- 1,300 feet from Mercy Health St. Elizabeth Campus


- Consistent Rent Growth

- Fresenius rent increases 3.5% Annually

- Mercy Health rent increases 2% Annually


- Priced Below Replacement Cost

- $175.77 PPSF creates barrier to entry for new construction limiting competition from entering the market.


- Excellent Historical Occupancy

- Fresenius has occupied for 34 Years


- New Lease Signed by Mercy Health

- Five Year term to commence upon completion of Landlord improvements


- Synergistic Tenant Mix

- Nephrology Practice Refers Patients to Dialysis Clinic


- Freestanding Medical Facility on Large Parcel

- Provides Visitors Easy Access and Ample Parking


- Anchor Tenant is Largest Dialysis Treatment Company Globally

- Fresenius Revenue Exceeds $19B Annually

- NYSE: FMS

Investment Highlights

  • - Fully Occupied Medical Office with Proximity to Hospital Campus - 1,300 feet from Mercy Health St. Elizabeth Campus
  • - Consistent Rent Growth - Fresenius rent increases 3.5% Annually - Mercy Health rent increases 2% Annually
  • - Priced Below Replacement Cost - $175.77 PPSF creates barrier to entry for new construction limiting competition from entering the market.
  • - Excellent Historical Occupancy - Fresenius has occupied for 34 Years
  • - New Lease Signed by Mercy Health - Five Year term to commence upon completion of Landlord improvements
  • - Synergistic Tenant Mix - Nephrology Practice Refers Patients to Dialysis Clinic
  • - Freestanding Medical Facility on Large Parcel - Provides Visitors Easy Access and Ample Parking
  • - Anchor Tenant is Largest Dialysis Treatment Company Globally - Fresenius Revenue Exceeds $19B Annually - NYSE: FMS

Exclusively Listed By

Broker of Record

  • Michael L. Glass

    Executive Managing Director / Chief Revenue Officer

    (614) 360-9800

    License(s) OH: BRK.2007005898

    Ohio

Financing By

Office Medical

Multi-Tenant Fresenius MOB

Listing Price: $4,150,000

Cap Rate
8.00%
Gross SF
23,611
Rentable SF
23,611
Price/Gross SF
$175.77
Occupancy
100.0%
Year Built
1954
Lot Size
1.50 acres

Investment Highlights

  • - Fully Occupied Medical Office with Proximity to Hospital Campus - 1,300 feet from Mercy Health St. Elizabeth Campus
  • - Consistent Rent Growth - Fresenius rent increases 3.5% Annually - Mercy Health rent increases 2% Annually
  • - Priced Below Replacement Cost - $175.77 PPSF creates barrier to entry for new construction limiting competition from entering the market.
  • - Excellent Historical Occupancy - Fresenius has occupied for 34 Years
  • - New Lease Signed by Mercy Health - Five Year term to commence upon completion of Landlord improvements
  • - Synergistic Tenant Mix - Nephrology Practice Refers Patients to Dialysis Clinic
  • - Freestanding Medical Facility on Large Parcel - Provides Visitors Easy Access and Ample Parking
  • - Anchor Tenant is Largest Dialysis Treatment Company Globally - Fresenius Revenue Exceeds $19B Annually - NYSE: FMS

Investment Overview

- Fully Occupied Medical Office with Proximity to Hospital Campus - 1,300 feet from Mercy Health St. Elizabeth Campus - Consistent Rent Growth - Fresenius rent increases 3.5% Annually - Mercy Health rent increases 2% Annually - Priced Below Replacement Cost - $175.77 PPSF creates barrier to entry for new construction limiting competition from entering the market. - Excellent Historical Occupancy - Fresenius has occupied for 34 Years - New Lease Signed by Mercy Health - Five Year term to commence upon completion of Landlord improvements - Synergistic Tenant Mix - Nephrology Practice Refers Patients to Dialysis Clinic - Freestanding Medical Facility on Large Parcel - Provides Visitors Easy Access and Ample Parking - Anchor Tenant is Largest Dialysis Treatment Company Globally - Fresenius Revenue Exceeds $19B Annually - NYSE: FMS

Exclusively Listed By

Broker of Record

  • Michael L. Glass

    Executive Managing Director / Chief Revenue Officer

    (614) 360-9800

    License(s): OH: BRK.2007005898

    Ohio

Financing By

MM Texture Background
MM Textured Background Lower